Clinical Trial Update: Safety and Efficacy of Marqibo in Metastatic Malignant Uveal Melanoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on safety and efficacy of Marqibo in metastatic malignant uveal melanoma has been completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Uveal Melanoma

Drugs mentioned

• Marqibo (vincristine liposome)

Snippet

Sponsor: Spectrum Pharmaceuticals, Inc | Conditions: Metastatic Malignant Uveal Melanoma | Phase 2 | Status: COMPLETED | Results posted: 2019-11-27